Cancer Pharmacogenomics: Germline DNA, Tumor DNA, or Both?
Journal:
Current Pharmacogenomics
Volume:
5
Page:
87-101
Author(s):
E. Cerri, A. Falcone and F. Innocenti
Pharmacogenomics in Colorectal Cancer
Journal:
Current Pharmacogenomics
Volume:
5
Page:
117-123
Author(s):
F. Meriggi, B. Di Biasi, C. Caliolo and A. Zaniboni
Pharmacogenetics of Oxazaphosphorines and its Clinical Implications
Journal:
Current Pharmacogenomics
Volume:
5
Page:
143-156
Author(s):
Shu-Feng Zhou, Balram Chowbay and Charlie Changli Xue
Glycoprotein Targeting and Other Applications of Lectins in Biotechnology
Journal:
Current Protein & Peptide Science
Volume:
8
Page:
261-271
Author(s):
Aabgeena Naeem, M. Saleemuddin and Rizwan Hasan Khan
The PYRIN Domain in Signal Transduction
Journal:
Current Protein & Peptide Science
Volume:
8
Page:
293-310
Author(s):
Christian Stehlik
The Anti-Cancer Charm of Flavonoids: A Cup-of-Tea Will Do!
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
109-117
Author(s):
Amr Amin and Michael Buratovich
Mechanisms to Inhibit Matrix Metalloproteinase Activity: Where are we in the Development of Clinically Relevant Inhibitors?
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
135-142
Author(s):
Christian A. Corbitt, Jing Lin and Merry L. Lindsey
Integrin αvβ3 Antagonists for Anti-Angiogenic Cancer Treatment
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
143-158
Author(s):
Andrew R. Hsu, Anand Veeravagu, Weibo Cai, Lewis C. Hou, Victor Tse and Xiaoyuan Chen
Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
175-186
Author(s):
Constantinos Mikelis, Marina Koutsioumpa and Evangelia Papadimitriou
Back to the Future: COX-2 Inhibitors for Chemoprevention and Cancer Therapy
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
7
Page:
599-608
Author(s):
Fazlul H. Sarkar, Shreelekha Adsule, Yiwei Li and Subhash Padhye